Cardiomyopathy
Cardiomyopathy | |
---|---|
Arrhythmogenic right ventricular dysplasia | |
Causes | |
Treatment | Depends on type and symptoms[5] |
Frequency | 2.5 million with myocarditis (2015)[6] |
Deaths | 354,000 with myocarditis (2015)[7] |
Cardiomyopathy is a group of primary diseases of the
As of 2013, cardiomyopathies are defined as "disorders characterized by morphologically and functionally abnormal myocardium in the absence of any other disease that is sufficient, by itself, to cause the observed phenotype."
In many cases, the cause cannot be determined.
Treatment depends on the type of cardiomyopathy and the severity of symptoms.
Signs and symptoms
Signs and symptoms of cardiomyopathy include:
- Shortness of breath or trouble breathing, especially with physical exertion
- Fatigue
- Swelling in the ankles, feet, legs, abdomen and veins in the neck
- Dizziness
- Lightheadedness
- Fainting during physical activity
- Arrhythmias (abnormal heartbeats)
- Chest pain, especially after physical exertion or heavy meals
- Heart murmurs (unusual sounds associated with heartbeats)
Causes
Cardiomyopathies can be of genetic (familial) or non-genetic (acquired) origin.[12] Genetic cardiomyopathies usually are caused by sarcomere or cytoskeletal diseases, neuromuscular disorders, inborn errors of metabolism, malformation syndromes and sometimes are unidentified.[13][14] Non-genetic cardiomyopathies can have definitive causes such as viral infections, myocarditis and others.[15][16]
Cardiomyopathies are either confined to the heart or are part of a generalized systemic disorder, both often leading to cardiovascular death or progressive heart failure-related disability. Other diseases that cause heart muscle dysfunction are excluded, such as
A more clinical categorization of cardiomyopathy as 'hypertrophied', 'dilated', or 'restrictive',[24] has become difficult to maintain because some of the conditions could fulfill more than one of those three categories at any particular stage of their development.[25]
The current American Heart Association (AHA) definition divides cardiomyopathies into primary, which affect the heart alone, and secondary, which are the result of illness affecting other parts of the body. These categories are further broken down into subgroups which incorporate new genetic and molecular biology knowledge.[26]
Mechanism
The pathophysiology of cardiomyopathies is better understood at the cellular level with advances in molecular techniques. Mutant proteins can disturb cardiac function in the contractile apparatus (or mechanosensitive complexes). Cardiomyocyte alterations and their persistent responses at the cellular level cause changes that are correlated with sudden cardiac death and other cardiac problems.[27]
Cardiomyopathies are generally varied individually. Different factors can cause Cardiomyopathies in adults as well as children. To exemplify, Dilated Cardiomyopathy in adults is associated with Ischemic Cardiomyopathy, Hypertension, Valvular diseases, and Genetics. While in Children, Neuromuscular diseases such as Becker muscular dystrophy, including X-linked genetic disorder, are directly linked with their Cardiomyopathies.[28]
Diagnosis
Among the diagnostic procedures done to determine a cardiomyopathy are:[29]
- Physical exam
- Family history
- Blood test
- ECG
- Echocardiogram
- Stress test
- Genetic testing
Classification
Cardiomyopathies can be classified using different criteria:[30]
- Primary/intrinsic cardiomyopathies[31]
- Congenital
- Hypertrophic cardiomyopathy (HCM)
- Arrhythmogenic right ventricular cardiomyopathy(ARVC)
- Left ventricular noncompaction
- Ion Channelopathies like the Long QT syndrome and the very rare Short QT syndrome
- Catecholaminergic polymorphic ventricular tachycardia
- Mixed
- Acquired
- Stress cardiomyopathy
- eosinophils[32]
- Ischemic cardiomyopathy (not formally included in the classification, due to ischemic cardiomyopathy being a direct result of another cardiac problem)[31]
- Congenital
- Secondary/extrinsic cardiomyopathies[31]
- Metabolic/storage
- Fabry's disease
- Hemochromatosis
- Endomyocardial
- Endomyocardial fibrosis
- Hypereosinophilic syndrome
- Endocrine
- Diabetes mellitus
- Hyperthyroidism
- Acromegaly
- Cardiofacial
- Neuromuscular
- Other
- Obesity-associated cardiomyopathy[34]
- Metabolic/storage
Treatment
Treatment may include suggestion of lifestyle changes to better manage the condition. Treatment depends on the type of cardiomyopathy and condition of disease, but may include medication (conservative treatment) or iatrogenic/implanted
See also
- Myopathy
- Fibrosing cardiomyopathy (disease in great apes)
- Basic Research in Cardiology
References
- ^ a b c d e f "What Are the Signs and Symptoms of Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
- ^ a b c "Who Is at Risk for Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 16 August 2016. Retrieved 31 August 2016.
- ^ a b c d e f g h "Types of Cardiomyopathy". NHLBI. 22 June 2016. Archived from the original on 28 July 2016. Retrieved 31 August 2016.
- ^ a b c d e "What Causes Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
- ^ a b c d "How Is Cardiomyopathy Treated?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
- ^ PMID 27733282.
- ^ PMID 27733281.
- ISBN 978-1-264-26850-4.
- S2CID 43240625.
- ISBN 978-1-60547-841-8. Archivedfrom the original on 14 September 2016.
- PMID 25530442.
- S2CID 44146977.
- PMID 34368032.
- PMID 30430036.
- PMID 32075145.
- PMID 33429969.
- ISBN 978-0-07-180215-4.
- OCLC 649701807.
- PMID 18578120.
- ^ S2CID 36117047.
- PMID 26763484.
- PMID 28932354.
- PMID 29056678.
- ISBN 978-0-07-143225-2. Archivedfrom the original on 27 May 2013. Retrieved 11 November 2010.
- PMID 35772124.
- PMID 22924131.
- PMID 21825071.
- S2CID 36384619.
- ^ a b "What Are the Signs and Symptoms of Cardiomyopathy? - NHLBI, NIH". nhlbi.nih.gov. Archived from the original on 28 July 2016. Retrieved 25 July 2016.
- ISBN 978-1-4377-1781-5.
- ^ from the original on 20 August 2016. Retrieved 1 August 2016.
- ^ PMID 25858537.
- PMID 27166925.
- ISBN 978-1-4471-2365-1. Archivedfrom the original on 29 May 2016.
Further reading
- Boudina S, Abel ED (1 March 2010). "Diabetic cardiomyopathy, causes and effects". Reviews in Endocrine & Metabolic Disorders. 11 (1): 31–39. PMID 20180026.
- Marian AJ, Roberts R (1 April 2001). "The Molecular Genetic Basis for Hypertrophic Cardiomyopathy". Journal of Molecular and Cellular Cardiology. 33 (4): 655–670. PMID 11273720.
- Acton QA (2013). Advances in Heart Research and Application: 2013 Edition. Scholarly Editions. ISBN 978-1-4816-8280-0.
- Towbin JA (2014). "Inherited cardiomyopathies". Circulation Journal. 78 (10): 2347–56. PMID 25186923.
- Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, Cooper LT, Link MS, Maron MS (1 December 2015). "Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology". Circulation. 132 (22): e273–280. S2CID 207639288.
External links
- Cardiomyopathy at Curlie